 BURLINGTON, Mass., Sept. 01, 2022 GLOBE NEWSWIRE -- scPharmaceuticals Inc. Nasdaq: SCPH, a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, announced today that John Tucker, president chief executive officer, is scheduled to present virtually at the H.C. Wainwright 24th Annual Global Investment Conference, which is being held in a hybrid format, in-person and virtually, from September 12-14 in New York. 